Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MCTA/Capital expenditures

Charming Medical Limited (MCTA) Capital expenditures 2024–2026

Charming Medical Limited (MCTA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$339,560FY2026 · since FY2024: $210,598 → $339,560
242526
Fiscal yearValueYoY
FY2026$339,560+18.1%
FY2025$287,527+36.5%
FY2024$210,598—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More MCTA financial trends

MCTA RevenueMCTA Net incomeMCTA Net marginMCTA Gross profitMCTA Gross marginMCTA Operating incomeMCTA Operating marginMCTA Operating cash flowMCTA Free cash flowMCTA Return on equityMCTA Stock buybacksMCTA Dividends paidMCTA Total assetsMCTA Total liabilitiesMCTA Shareholders’ equityMCTA overview →